Home

Jeffrey Z Mann

CIK 1784562 · Pres, Pharm Svc&Prod Mgmt, CLO · last filed 2026-08-13

Jeffrey Z Mann is a Pres, Pharm Svc&Prod Mgmt, CLO who has filed 17 SEC Form 4 insider transactions across 2 companies since 2019. The most recent filing shows the insider bought $99.8K of EMBC on Aug 13, 2026. Across all open-market trades the lifetime net is +$252.1K, making them a net buyer over the disclosed history. Current disclosed insider exposure totals $1.3M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$1.30M

Companies

2

Total Filings

17

Lifetime Open-Market Net

$252.1K

Filer Profile

Reported Address
150 CLOVE ROAD, 9TH FLOOR
LITTLE FALLS, NJ 07424
Profile details as reported on the filer's SEC submissions — for individual insiders the address is often in care of the issuer. Related filers are identified from jointly filed SEC submissions and shared reported addresses. View filings on SEC EDGAR.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
EMBC Pres, Pharm Svc&Prod Mgmt, CLO 262,915 $4.94 $1.30M $201.6K 10 2026-08-13
CANTEL MEDICAL CORP (CMD) Delisted SVP, General Counsel 0 $80.37 $0 $50.5K 7 2021-06-02

Recent Filings

17 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-08-13 EMBC Buy (P) +20,000 $99.8K EDGAR
2025-12-03 EMBC — — $0 EDGAR
2025-12-01 EMBC Mixed +84,445 -$246.4K EDGAR
2025-04-08 EMBC Tax (F) −5,285 -$63.4K EDGAR
2024-11-29 EMBC Mixed +42,787 -$149.9K EDGAR
2023-11-28 EMBC Mixed +42,026 -$65.0K EDGAR
2023-08-10 EMBC Buy (P) +4,700 $101.8K EDGAR
2022-11-29 EMBC Mixed +18,243 -$47.3K EDGAR
2022-05-12 EMBC Mixed +17,813 $0 EDGAR
2022-04-06 EMBC Grant (A) +16,281 $0 EDGAR
Showing 1–10 of 17
Page 1 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.